SlideShare una empresa de Scribd logo

Biotechnology Novelty And Nonobviousness 14 Sep10

•Descargar como PPT, PDF•
•
Gary M. Myles, Ph.D.
Gary M. Myles, Ph.D.
1 de 52
Biotechnology Patent Prosecution – Part 1 Novelty and Nonobviousness Gary M. Myles, Ph.D. Biotechnology and the Law Seattle University School of Law September 14, 2010
The Statutory Requirements for Patentability ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The Statutory Requirements for Patentability ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Novelty and Staturory Bars ,[object Object],[object Object],[object Object],[object Object]
Novelty (102(a), (e) and (g)) ,[object Object],[object Object],[object Object]
Statutory Bars (102(b) and (d)) ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Test for Novelty ,[object Object],[object Object],[object Object]
Inherent Anticipation ,[object Object]
Inherent Anticipation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Inherent Anticipation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Inherent Anticipation ,[object Object],[object Object],[object Object]
Inherent Anticipation ,[object Object],[object Object],[object Object]
Inherent Anticipation ,[object Object],[object Object],[object Object],[object Object]
Impact on Patent Prosecution ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Non-obviousness ,[object Object],[object Object]
Evolution of Modern Obviousness ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],Evolution of Modern Obviousness
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Evolution of Modern Obviousness
[object Object],[object Object],[object Object],[object Object],Evolution of Modern Obviousness
[object Object],[object Object],[object Object],[object Object],Evolution of Modern Obviousness
[object Object],[object Object],[object Object],[object Object],Evolution of Modern Obviousness
[object Object],[object Object],[object Object],[object Object],[object Object],Evolution of Modern Obviousness
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],KSR v. Teleflex (S. Ct. 2007) Adjustable pedal assembly Electronic throttle control
KSR v. Teleflex (S. Ct. 2007) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
KSR v. Teleflex (S. Ct. 2007) ,[object Object],[object Object],[object Object]
KSR v. Teleflex (S. Ct. 2007) ,[object Object],[object Object],[object Object],[object Object]
KSR v. Teleflex (S. Ct. 2007) ,[object Object],[object Object],[object Object]
KSR v. Teleflex (S. Ct. 2007) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
KSR v. Teleflex (S. Ct. 2007) ,[object Object],[object Object],[object Object],[object Object]
KSR v. Teleflex (S. Ct. 2007) ,[object Object],[object Object],[object Object]
Lessons from KSR ,[object Object],[object Object],[object Object]
Lessons from KSR ,[object Object],[object Object],[object Object],[object Object]
Obviousness at the USPTO ,[object Object],[object Object],[object Object],[object Object],[object Object]
Obviousness at the USPTO ,[object Object],[object Object],[object Object],[object Object]
Syngenta Seeds v. Monsanto (Fed. Cir. 2007) (unpublished) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Syngenta Seeds v. Monsanto (Fed. Cir. 2007) (unpublished) ,[object Object],[object Object],[object Object],[object Object]
Aventis v. Lupin (Fed. Cir. 2007) ,[object Object],[object Object],[object Object],[object Object]
Aventis v. Lupin (Fed. Cir. 2007) ,[object Object],[object Object],[object Object]
Takeda v. Alphapharm (Fed. Cir. 2007) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Takeda v. Alphapharm (Fed. Cir. 2007) ,[object Object],[object Object],[object Object],[object Object],[object Object]
In re Deuel (Fed. Cir. 1995) ,[object Object],[object Object],[object Object]
In re Deuel (Fed. Cir. 1995) ,[object Object],[object Object],[object Object],[object Object]
In re Deuel (Fed. Cir. 1995) ,[object Object],[object Object]
In re Deuel (Fed. Cir. 1995) ,[object Object]
Ex parte Kubin ( B.P.A.I. 2007) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Ex parte Kubin ( B.P.A.I. 2007) ,[object Object],[object Object],[object Object],[object Object],[object Object]
In re Kubin (Fed. Cir. 2009) ,[object Object],[object Object]
In re Kubin (Fed. Cir. 2009) ,[object Object],[object Object]
Overcoming Obviousness Post-KSR ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Scenario 1: Structural Similarity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Scenario 2: Purification ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Scenario 3: Combination ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Recomendados

2017 01-25 uwls-apl_biotech 112
2017 01-25 uwls-apl_biotech 1122017 01-25 uwls-apl_biotech 112
2017 01-25 uwls-apl_biotech 112Gary M. Myles, Ph.D.
 
Inventorship
InventorshipInventorship
Inventorshipstantolin
 
European & us patent law module3 2013 updated
European & us patent law module3 2013 updatedEuropean & us patent law module3 2013 updated
European & us patent law module3 2013 updatedIP Dome
 
I’m so confused — what is prior art now?
I’m so confused — what is prior art now? I’m so confused — what is prior art now?
I’m so confused — what is prior art now? Marc Hubbard
 
May 2015 Administrative Estoppel Presentation
May 2015 Administrative Estoppel PresentationMay 2015 Administrative Estoppel Presentation
May 2015 Administrative Estoppel PresentationWoodard, Emhardt, Henry, Reeves & Wagner, LLP
 
July 2015 Patent Case Update
July 2015 Patent Case UpdateJuly 2015 Patent Case Update
July 2015 Patent Case UpdateWoodard, Emhardt, Henry, Reeves & Wagner, LLP
 
2003 oct15ans
2003 oct15ans2003 oct15ans
2003 oct15ansLeon Li
 
First-Inventor-to-File (FITF)
First-Inventor-to-File (FITF)First-Inventor-to-File (FITF)
First-Inventor-to-File (FITF)Patterson Thuente IP
 

Recomendados

2017 01-25 uwls-apl_biotech 112
2017 01-25 uwls-apl_biotech 1122017 01-25 uwls-apl_biotech 112
2017 01-25 uwls-apl_biotech 112Gary M. Myles, Ph.D.
 
Inventorship
InventorshipInventorship
Inventorshipstantolin
 
European & us patent law module3 2013 updated
European & us patent law module3 2013 updatedEuropean & us patent law module3 2013 updated
European & us patent law module3 2013 updatedIP Dome
 
I’m so confused — what is prior art now?
I’m so confused — what is prior art now? I’m so confused — what is prior art now?
I’m so confused — what is prior art now? Marc Hubbard
 
May 2015 Administrative Estoppel Presentation
May 2015 Administrative Estoppel PresentationMay 2015 Administrative Estoppel Presentation
May 2015 Administrative Estoppel PresentationWoodard, Emhardt, Henry, Reeves & Wagner, LLP
 
July 2015 Patent Case Update
July 2015 Patent Case UpdateJuly 2015 Patent Case Update
July 2015 Patent Case UpdateWoodard, Emhardt, Henry, Reeves & Wagner, LLP
 
2003 oct15ans
2003 oct15ans2003 oct15ans
2003 oct15ansLeon Li
 
First-Inventor-to-File (FITF)
First-Inventor-to-File (FITF)First-Inventor-to-File (FITF)
First-Inventor-to-File (FITF)Patterson Thuente IP
 
May 2015 Litigation Lunch
May 2015 Litigation LunchMay 2015 Litigation Lunch
May 2015 Litigation LunchWoodard, Emhardt, Henry, Reeves & Wagner, LLP
 
October 2014 Patent Luncheon Slides
October 2014 Patent Luncheon SlidesOctober 2014 Patent Luncheon Slides
October 2014 Patent Luncheon SlidesWoodard, Emhardt, Henry, Reeves & Wagner, LLP
 
Review of Recent IP Supreme Court Cases
Review of Recent IP Supreme Court CasesReview of Recent IP Supreme Court Cases
Review of Recent IP Supreme Court CasesWoodard, Emhardt, Henry, Reeves & Wagner, LLP
 
The America Invents Act Turns Traditional Patent Practices into a Thing of th...
The America Invents Act Turns Traditional Patent Practices into a Thing of th...The America Invents Act Turns Traditional Patent Practices into a Thing of th...
The America Invents Act Turns Traditional Patent Practices into a Thing of th...Armstrong Teasdale
 
DOCKET - Andrea Constand vs William H Cosby
DOCKET - Andrea Constand vs William H CosbyDOCKET - Andrea Constand vs William H Cosby
DOCKET - Andrea Constand vs William H CosbyVogelDenise
 
Patent bar practice questions october 2003
Patent bar practice questions october 2003Patent bar practice questions october 2003
Patent bar practice questions october 2003Bradley Sands
 
SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.
SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.
SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.Patrick Delaney
 
Patent bar practice questions april 2003
Patent bar practice questions april 2003Patent bar practice questions april 2003
Patent bar practice questions april 2003Bradley Sands
 
Biotechnology Enablement And Written Description 28 Sep10
Biotechnology Enablement And Written Description 28 Sep10Biotechnology Enablement And Written Description 28 Sep10
Biotechnology Enablement And Written Description 28 Sep10Gary M. Myles, Ph.D.
 
Weatherhead JPTOS 2015
Weatherhead JPTOS 2015Weatherhead JPTOS 2015
Weatherhead JPTOS 2015Robin Weatherhead
 
Stronger Life Science Patents (MichBio)
Stronger Life Science Patents (MichBio)Stronger Life Science Patents (MichBio)
Stronger Life Science Patents (MichBio)Aurora Consulting
 
European and US Patent Law
European and US Patent LawEuropean and US Patent Law
European and US Patent LawIP Dome
 
Post-KSR Obviousness
Post-KSR ObviousnessPost-KSR Obviousness
Post-KSR ObviousnessGary M. Myles, Ph.D.
 
Patent Eligibility's Common Stock Theory
Patent Eligibility's Common Stock TheoryPatent Eligibility's Common Stock Theory
Patent Eligibility's Common Stock TheoryRobert DeWitty
 
Patentability of Diagnostic Inventions
Patentability of Diagnostic InventionsPatentability of Diagnostic Inventions
Patentability of Diagnostic InventionsMarcus A. Streips
 
04-Patentable Subject Matter 35 USC §101
04-Patentable Subject Matter 35 USC §10104-Patentable Subject Matter 35 USC §101
04-Patentable Subject Matter 35 USC §101MacMillan, Sobanski and Todd, LLC.
 
Pitfalls and Strategies to Avoid Charges of Inequitable Conduct
Pitfalls and Strategies to Avoid Charges of Inequitable ConductPitfalls and Strategies to Avoid Charges of Inequitable Conduct
Pitfalls and Strategies to Avoid Charges of Inequitable ConductWoodard, Emhardt, Henry, Reeves & Wagner, LLP
 
03-Brief Overview of U.S. Utility Patent Law and Practice
03-Brief Overview of U.S. Utility Patent Law and Practice03-Brief Overview of U.S. Utility Patent Law and Practice
03-Brief Overview of U.S. Utility Patent Law and PracticeMacMillan, Sobanski and Todd, LLC.
 
Ariad and Written Description
Ariad and Written DescriptionAriad and Written Description
Ariad and Written Descriptionpmrivard
 
Stephen Milbrath - Florida Bar
Stephen Milbrath - Florida BarStephen Milbrath - Florida Bar
Stephen Milbrath - Florida Barisighttech
 
2009 Nciia Presentation
2009 Nciia Presentation2009 Nciia Presentation
2009 Nciia Presentationthe nciia
 
Willful Patent Infringement
Willful Patent InfringementWillful Patent Infringement
Willful Patent Infringementprofberry
 

Más contenido relacionado

La actualidad más candente

The America Invents Act Turns Traditional Patent Practices into a Thing of th...
The America Invents Act Turns Traditional Patent Practices into a Thing of th...The America Invents Act Turns Traditional Patent Practices into a Thing of th...
The America Invents Act Turns Traditional Patent Practices into a Thing of th...Armstrong Teasdale
 
DOCKET - Andrea Constand vs William H Cosby
DOCKET - Andrea Constand vs William H CosbyDOCKET - Andrea Constand vs William H Cosby
DOCKET - Andrea Constand vs William H CosbyVogelDenise
 
Patent bar practice questions october 2003
Patent bar practice questions october 2003Patent bar practice questions october 2003
Patent bar practice questions october 2003Bradley Sands
 
SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.
SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.
SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.Patrick Delaney
 
Patent bar practice questions april 2003
Patent bar practice questions april 2003Patent bar practice questions april 2003
Patent bar practice questions april 2003Bradley Sands
 

La actualidad más candente (8)

May 2015 Litigation Lunch
May 2015 Litigation LunchMay 2015 Litigation Lunch
May 2015 Litigation Lunch
 
October 2014 Patent Luncheon Slides
October 2014 Patent Luncheon SlidesOctober 2014 Patent Luncheon Slides
October 2014 Patent Luncheon Slides
 
Review of Recent IP Supreme Court Cases
Review of Recent IP Supreme Court CasesReview of Recent IP Supreme Court Cases
Review of Recent IP Supreme Court Cases
 
The America Invents Act Turns Traditional Patent Practices into a Thing of th...
The America Invents Act Turns Traditional Patent Practices into a Thing of th...The America Invents Act Turns Traditional Patent Practices into a Thing of th...
The America Invents Act Turns Traditional Patent Practices into a Thing of th...
 
DOCKET - Andrea Constand vs William H Cosby
DOCKET - Andrea Constand vs William H CosbyDOCKET - Andrea Constand vs William H Cosby
DOCKET - Andrea Constand vs William H Cosby
 
Patent bar practice questions october 2003
Patent bar practice questions october 2003Patent bar practice questions october 2003
Patent bar practice questions october 2003
 
SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.
SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.
SCOTUS Amicus Brief filed in Alice Corp. v CLS Bank case.
 
Patent bar practice questions april 2003
Patent bar practice questions april 2003Patent bar practice questions april 2003
Patent bar practice questions april 2003
 

Similar a Biotechnology Novelty And Nonobviousness 14 Sep10

Biotechnology Enablement And Written Description 28 Sep10
Biotechnology Enablement And Written Description 28 Sep10Biotechnology Enablement And Written Description 28 Sep10
Biotechnology Enablement And Written Description 28 Sep10Gary M. Myles, Ph.D.
 
Stronger Life Science Patents (MichBio)
Stronger Life Science Patents (MichBio)Stronger Life Science Patents (MichBio)
Stronger Life Science Patents (MichBio)Aurora Consulting
 
European and US Patent Law
European and US Patent LawEuropean and US Patent Law
European and US Patent LawIP Dome
 
Patent Eligibility's Common Stock Theory
Patent Eligibility's Common Stock TheoryPatent Eligibility's Common Stock Theory
Patent Eligibility's Common Stock TheoryRobert DeWitty
 
Patentability of Diagnostic Inventions
Patentability of Diagnostic InventionsPatentability of Diagnostic Inventions
Patentability of Diagnostic InventionsMarcus A. Streips
 
Ariad and Written Description
Ariad and Written DescriptionAriad and Written Description
Ariad and Written Descriptionpmrivard
 
Stephen Milbrath - Florida Bar
Stephen Milbrath - Florida BarStephen Milbrath - Florida Bar
Stephen Milbrath - Florida Barisighttech
 
2009 Nciia Presentation
2009 Nciia Presentation2009 Nciia Presentation
2009 Nciia Presentationthe nciia
 
Willful Patent Infringement
Willful Patent InfringementWillful Patent Infringement
Willful Patent Infringementprofberry
 
Biotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After BilskiBiotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After Bilskiwardjohn1346
 
Creat Act Talk 2015_Jan
Creat Act Talk 2015_JanCreat Act Talk 2015_Jan
Creat Act Talk 2015_JanW. John Keyes
 
Unintended Consequences of Joint Patent Ownership
Unintended Consequences of Joint Patent OwnershipUnintended Consequences of Joint Patent Ownership
Unintended Consequences of Joint Patent OwnershipRodney Sparks
 
The CREATE Act -- As viewed from the Ivory Towers and from the Trenches
The CREATE Act -- As viewed from the Ivory Towers and from the TrenchesThe CREATE Act -- As viewed from the Ivory Towers and from the Trenches
The CREATE Act -- As viewed from the Ivory Towers and from the TrenchesKevin E. Flynn
 

Similar a Biotechnology Novelty And Nonobviousness 14 Sep10 (20)

Biotechnology Enablement And Written Description 28 Sep10
Biotechnology Enablement And Written Description 28 Sep10Biotechnology Enablement And Written Description 28 Sep10
Biotechnology Enablement And Written Description 28 Sep10
 
Weatherhead JPTOS 2015
Weatherhead JPTOS 2015Weatherhead JPTOS 2015
Weatherhead JPTOS 2015
 
Stronger Life Science Patents (MichBio)
Stronger Life Science Patents (MichBio)Stronger Life Science Patents (MichBio)
Stronger Life Science Patents (MichBio)
 
European and US Patent Law
European and US Patent LawEuropean and US Patent Law
European and US Patent Law
 
Post-KSR Obviousness
Post-KSR ObviousnessPost-KSR Obviousness
Post-KSR Obviousness
 
Patent Eligibility's Common Stock Theory
Patent Eligibility's Common Stock TheoryPatent Eligibility's Common Stock Theory
Patent Eligibility's Common Stock Theory
 
Patentability of Diagnostic Inventions
Patentability of Diagnostic InventionsPatentability of Diagnostic Inventions
Patentability of Diagnostic Inventions
 
04-Patentable Subject Matter 35 USC §101
04-Patentable Subject Matter 35 USC §10104-Patentable Subject Matter 35 USC §101
04-Patentable Subject Matter 35 USC §101
 
Pitfalls and Strategies to Avoid Charges of Inequitable Conduct
Pitfalls and Strategies to Avoid Charges of Inequitable ConductPitfalls and Strategies to Avoid Charges of Inequitable Conduct
Pitfalls and Strategies to Avoid Charges of Inequitable Conduct
 
03-Brief Overview of U.S. Utility Patent Law and Practice
03-Brief Overview of U.S. Utility Patent Law and Practice03-Brief Overview of U.S. Utility Patent Law and Practice
03-Brief Overview of U.S. Utility Patent Law and Practice
 
Ariad and Written Description
Ariad and Written DescriptionAriad and Written Description
Ariad and Written Description
 
Stephen Milbrath - Florida Bar
Stephen Milbrath - Florida BarStephen Milbrath - Florida Bar
Stephen Milbrath - Florida Bar
 
2009 Nciia Presentation
2009 Nciia Presentation2009 Nciia Presentation
2009 Nciia Presentation
 
Willful Patent Infringement
Willful Patent InfringementWillful Patent Infringement
Willful Patent Infringement
 
Prosecution estoppel
Prosecution estoppelProsecution estoppel
Prosecution estoppel
 
06-Patent Non-Obviousness 35 USC §103
06-Patent Non-Obviousness 35 USC §10306-Patent Non-Obviousness 35 USC §103
06-Patent Non-Obviousness 35 USC §103
 
Biotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After BilskiBiotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After Bilski
 
Creat Act Talk 2015_Jan
Creat Act Talk 2015_JanCreat Act Talk 2015_Jan
Creat Act Talk 2015_Jan
 
Unintended Consequences of Joint Patent Ownership
Unintended Consequences of Joint Patent OwnershipUnintended Consequences of Joint Patent Ownership
Unintended Consequences of Joint Patent Ownership
 
The CREATE Act -- As viewed from the Ivory Towers and from the Trenches
The CREATE Act -- As viewed from the Ivory Towers and from the TrenchesThe CREATE Act -- As viewed from the Ivory Towers and from the Trenches
The CREATE Act -- As viewed from the Ivory Towers and from the Trenches
 

Más de Gary M. Myles, Ph.D.

2020 01-28 uwls-apl_biotech_disclosure under 35_usc112
2020 01-28 uwls-apl_biotech_disclosure under 35_usc1122020 01-28 uwls-apl_biotech_disclosure under 35_usc112
2020 01-28 uwls-apl_biotech_disclosure under 35_usc112Gary M. Myles, Ph.D.
 
Commil v. Cisco: Brief of Biotechnology Industry Organization as Amicus Curi...
Commil v. Cisco: Brief of Biotechnology Industry Organization as Amicus Curi...Commil v. Cisco: Brief of Biotechnology Industry Organization as Amicus Curi...
Commil v. Cisco: Brief of Biotechnology Industry Organization as Amicus Curi...Gary M. Myles, Ph.D.
 
Myriad Decision May Invalidate Many Patents
Myriad Decision May Invalidate Many PatentsMyriad Decision May Invalidate Many Patents
Myriad Decision May Invalidate Many PatentsGary M. Myles, Ph.D.
 
COMMIL v. CISCO_Brief of Biotechnology Industry Organization (BIO) as Amicus ...
COMMIL v. CISCO_Brief of Biotechnology Industry Organization (BIO) as Amicus ...COMMIL v. CISCO_Brief of Biotechnology Industry Organization (BIO) as Amicus ...
COMMIL v. CISCO_Brief of Biotechnology Industry Organization (BIO) as Amicus ...Gary M. Myles, Ph.D.
 
2015-11-4_WSU_Defining a Corporate Structure for a Startup Company
2015-11-4_WSU_Defining a Corporate Structure for a Startup Company2015-11-4_WSU_Defining a Corporate Structure for a Startup Company
2015-11-4_WSU_Defining a Corporate Structure for a Startup CompanyGary M. Myles, Ph.D.
 
2015-11-4_WSU_Corp Structure & Formation for Start-ups
2015-11-4_WSU_Corp Structure & Formation for Start-ups2015-11-4_WSU_Corp Structure & Formation for Start-ups
2015-11-4_WSU_Corp Structure & Formation for Start-upsGary M. Myles, Ph.D.
 
Aziz Sancar 2015 Nobel Prize in Chemistry
Aziz Sancar 2015 Nobel Prize in ChemistryAziz Sancar 2015 Nobel Prize in Chemistry
Aziz Sancar 2015 Nobel Prize in ChemistryGary M. Myles, Ph.D.
 
13-896; tsac; Biotechnology Industry Organization
13-896; tsac; Biotechnology Industry Organization13-896; tsac; Biotechnology Industry Organization
13-896; tsac; Biotechnology Industry OrganizationGary M. Myles, Ph.D.
 
Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...
Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...
Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...Gary M. Myles, Ph.D.
 
Protecting the Inventions of Start-ups
Protecting the Inventions of Start-upsProtecting the Inventions of Start-ups
Protecting the Inventions of Start-upsGary M. Myles, Ph.D.
 
Preparing for a Financial Audit & Corporate Due Diligence
Preparing for a Financial Audit & Corporate Due DiligencePreparing for a Financial Audit & Corporate Due Diligence
Preparing for a Financial Audit & Corporate Due DiligenceGary M. Myles, Ph.D.
 
Gary M. Myles, J.D., Ph.D. -- Biotechnology, Life Sciences, and Pharmaceutica...
Gary M. Myles, J.D., Ph.D. -- Biotechnology, Life Sciences, and Pharmaceutica...Gary M. Myles, J.D., Ph.D. -- Biotechnology, Life Sciences, and Pharmaceutica...
Gary M. Myles, J.D., Ph.D. -- Biotechnology, Life Sciences, and Pharmaceutica...Gary M. Myles, Ph.D.
 
CASRIP 2012 -- Patenting of Human DNA and Embryos
CASRIP 2012 -- Patenting of Human DNA and EmbryosCASRIP 2012 -- Patenting of Human DNA and Embryos
CASRIP 2012 -- Patenting of Human DNA and EmbryosGary M. Myles, Ph.D.
 
America Invents Act: Recent Changes to US Patent Law and Practice
America Invents Act: Recent Changes to US Patent Law and PracticeAmerica Invents Act: Recent Changes to US Patent Law and Practice
America Invents Act: Recent Changes to US Patent Law and PracticeGary M. Myles, Ph.D.
 
Les Aia Stanford And Effect Of Valuation 09 Nov11
Les Aia Stanford And Effect Of Valuation 09 Nov11Les Aia Stanford And Effect Of Valuation 09 Nov11
Les Aia Stanford And Effect Of Valuation 09 Nov11Gary M. Myles, Ph.D.
 
Patenting In The Biotech Industry 21 Sep10
Patenting In The Biotech Industry 21 Sep10Patenting In The Biotech Industry 21 Sep10
Patenting In The Biotech Industry 21 Sep10Gary M. Myles, Ph.D.
 
Career Options Life Scientist 04Jun10
Career Options Life Scientist 04Jun10Career Options Life Scientist 04Jun10
Career Options Life Scientist 04Jun10Gary M. Myles, Ph.D.
 
Biotechnology Written Description, Enablement, and Patent Eligibility
Biotechnology Written Description, Enablement, and Patent EligibilityBiotechnology Written Description, Enablement, and Patent Eligibility
Biotechnology Written Description, Enablement, and Patent EligibilityGary M. Myles, Ph.D.
 

Más de Gary M. Myles, Ph.D. (20)

2020 01-28 uwls-apl_biotech_disclosure under 35_usc112
2020 01-28 uwls-apl_biotech_disclosure under 35_usc1122020 01-28 uwls-apl_biotech_disclosure under 35_usc112
2020 01-28 uwls-apl_biotech_disclosure under 35_usc112
 
Commil v. Cisco: Brief of Biotechnology Industry Organization as Amicus Curi...
Commil v. Cisco: Brief of Biotechnology Industry Organization as Amicus Curi...Commil v. Cisco: Brief of Biotechnology Industry Organization as Amicus Curi...
Commil v. Cisco: Brief of Biotechnology Industry Organization as Amicus Curi...
 
Myriad Decision May Invalidate Many Patents
Myriad Decision May Invalidate Many PatentsMyriad Decision May Invalidate Many Patents
Myriad Decision May Invalidate Many Patents
 
COMMIL v. CISCO_Brief of Biotechnology Industry Organization (BIO) as Amicus ...
COMMIL v. CISCO_Brief of Biotechnology Industry Organization (BIO) as Amicus ...COMMIL v. CISCO_Brief of Biotechnology Industry Organization (BIO) as Amicus ...
COMMIL v. CISCO_Brief of Biotechnology Industry Organization (BIO) as Amicus ...
 
2017 02-15 uwls-apl_biotech 101
2017 02-15 uwls-apl_biotech 1012017 02-15 uwls-apl_biotech 101
2017 02-15 uwls-apl_biotech 101
 
2015-11-4_WSU_Defining a Corporate Structure for a Startup Company
2015-11-4_WSU_Defining a Corporate Structure for a Startup Company2015-11-4_WSU_Defining a Corporate Structure for a Startup Company
2015-11-4_WSU_Defining a Corporate Structure for a Startup Company
 
2015-11-4_WSU_Corp Structure & Formation for Start-ups
2015-11-4_WSU_Corp Structure & Formation for Start-ups2015-11-4_WSU_Corp Structure & Formation for Start-ups
2015-11-4_WSU_Corp Structure & Formation for Start-ups
 
Aziz Sancar 2015 Nobel Prize in Chemistry
Aziz Sancar 2015 Nobel Prize in ChemistryAziz Sancar 2015 Nobel Prize in Chemistry
Aziz Sancar 2015 Nobel Prize in Chemistry
 
13-896; tsac; Biotechnology Industry Organization
13-896; tsac; Biotechnology Industry Organization13-896; tsac; Biotechnology Industry Organization
13-896; tsac; Biotechnology Industry Organization
 
Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...
Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...
Merchant & Gould Whitepaper: Association of Molecular Pathology v. Myriad Ge...
 
Protecting the Inventions of Start-ups
Protecting the Inventions of Start-upsProtecting the Inventions of Start-ups
Protecting the Inventions of Start-ups
 
Preparing for a Financial Audit & Corporate Due Diligence
Preparing for a Financial Audit & Corporate Due DiligencePreparing for a Financial Audit & Corporate Due Diligence
Preparing for a Financial Audit & Corporate Due Diligence
 
Gary M. Myles, J.D., Ph.D. -- Biotechnology, Life Sciences, and Pharmaceutica...
Gary M. Myles, J.D., Ph.D. -- Biotechnology, Life Sciences, and Pharmaceutica...Gary M. Myles, J.D., Ph.D. -- Biotechnology, Life Sciences, and Pharmaceutica...
Gary M. Myles, J.D., Ph.D. -- Biotechnology, Life Sciences, and Pharmaceutica...
 
CASRIP 2012 -- Patenting of Human DNA and Embryos
CASRIP 2012 -- Patenting of Human DNA and EmbryosCASRIP 2012 -- Patenting of Human DNA and Embryos
CASRIP 2012 -- Patenting of Human DNA and Embryos
 
America Invents Act: Recent Changes to US Patent Law and Practice
America Invents Act: Recent Changes to US Patent Law and PracticeAmerica Invents Act: Recent Changes to US Patent Law and Practice
America Invents Act: Recent Changes to US Patent Law and Practice
 
Biotechnology Patent Eligibility
Biotechnology Patent EligibilityBiotechnology Patent Eligibility
Biotechnology Patent Eligibility
 
Les Aia Stanford And Effect Of Valuation 09 Nov11
Les Aia Stanford And Effect Of Valuation 09 Nov11Les Aia Stanford And Effect Of Valuation 09 Nov11
Les Aia Stanford And Effect Of Valuation 09 Nov11
 
Patenting In The Biotech Industry 21 Sep10
Patenting In The Biotech Industry 21 Sep10Patenting In The Biotech Industry 21 Sep10
Patenting In The Biotech Industry 21 Sep10
 
Career Options Life Scientist 04Jun10
Career Options Life Scientist 04Jun10Career Options Life Scientist 04Jun10
Career Options Life Scientist 04Jun10
 
Biotechnology Written Description, Enablement, and Patent Eligibility
Biotechnology Written Description, Enablement, and Patent EligibilityBiotechnology Written Description, Enablement, and Patent Eligibility
Biotechnology Written Description, Enablement, and Patent Eligibility
 

Biotechnology Novelty And Nonobviousness 14 Sep10

  • 1. Biotechnology Patent Prosecution – Part 1 Novelty and Nonobviousness Gary M. Myles, Ph.D. Biotechnology and the Law Seattle University School of Law September 14, 2010
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.